 |
| Editorial |  Top |
|
 |
 |
Focus on Antibody Engineering and Manufacture
King in the kingdom of uncertainty p1025
doi:10.1038/nbt0905-1025
Full text | PDF
(72K)
|
|
| News | Top |
|
|
|
Focus on Antibody Engineering and Manufacture
Profile: Lisa Drakeman p1035
Laura DeFrancesco
Published online: 31 August 2005 | doi:10.1038/nbt0905-1035
Abstract | Full text | PDF
(59K)
|
|
 |
|
| News Feature |
|
|
|
Focus on Antibody Engineering and Manufacture
The problem with potency pp1037 - 1039
Christopher Thomas Scott
Published online: 31 August 2005 | doi:10.1038/nbt0905-1037
Abstract | Full text | PDF
(131K)
|
|
| Opinion and Comment | Top |
|
 |
|
| Commentary |
|
|
|
Focus on Antibody Engineering and Manufacture
Empowering the inventor—the case of monoclonal antibodies pp1047 - 1049
Mike Clark
doi:10.1038/nbt0905-1047
Abstract | Full text | PDF
(92K)
|
|
|
|
Focus on Antibody Engineering and Manufacture
Overhauling oversight—European drug legislation pp1050 - 1053
Lincoln Tsang
doi:10.1038/nbt0905-1050
Abstract | Full text | PDF
(178K)
|
|
|
|
Focus on Antibody Engineering and Manufacture
Flexibility—the guiding principle for antibody manufacturing pp1054 - 1058
Keith L Carson
doi:10.1038/nbt0905-1054
Abstract | Full text | PDF
(1,171K)
|
|
| Features | Top |
|
|
|
Focus on Antibody Engineering and Manufacture
Upping the ante on antibodies pp1065 - 1072
Monya Baker
doi:10.1038/nbt0905-1065
Abstract | Full text | PDF
(198K)
|
|
|
|
Focus on Antibody Engineering and Manufacture
Monoclonal antibody successes in the clinic pp1073 - 1078
Janice M Reichert, Clark J Rosensweig, Laura B Faden
& Matthew C Dewitz
doi:10.1038/nbt0905-1073
Abstract | Full text | PDF
(276K)
|
|
|
|
| Patents |
|
|
|
Focus on Antibody Engineering and Manufacture
The patentability of antibodies in the United States pp1079 - 1080
Deborah L Lu, Angela M Collison
& Thomas J Kowalski
doi:10.1038/nbt0905-1079
Abstract | Full text | PDF
(44K)
|
|
|
|
Focus on Antibody Engineering and Manufacture
Recent patent applications related to antibodies p1081
doi:10.1038/nbt0905-1081
Full text | PDF
(29K)
|
|
| Research | Top |
|
|
|
| Reviews |
|
|
|
Focus on Antibody Engineering and Manufacture
Selecting and screening recombinant antibody libraries pp1105 - 1116
Hennie R Hoogenboom
Published online: 07 September 2005 | doi:10.1038/nbt1126
Abstract | Full text | PDF
(2,062K)
|
|
|
|
Focus on Antibody Engineering and Manufacture
Human antibodies from transgenic animals pp1117 - 1125
Nils Lonberg
Published online: 07 September 2005 | doi:10.1038/nbt1135
Abstract | Full text | PDF
(3,019K)
|
|
|
|
Focus on Antibody Engineering and Manufacture
Engineered antibody fragments and the rise of single domains pp1126 - 1136
Philipp Holliger
& Peter J Hudson
Published online: 07 September 2005 | doi:10.1038/nbt1142
Abstract | Full text | PDF
(1,892K)
|
|
|
|
Focus on Antibody Engineering and Manufacture
Arming antibodies: prospects and challenges for immunoconjugates pp1137 - 1146
Anna M Wu
& Peter D Senter
Published online: 07 September 2005 | doi:10.1038/nbt1141
Abstract | Full text | PDF
(1,183K)
|
|
|
|
Focus on Antibody Engineering and Manufacture
Monoclonal antibody therapy of cancer pp1147 - 1157
Gregory P Adams
& Louis M Weiner
Published online: 07 September 2005 | doi:10.1038/nbt1137
Abstract | Full text | PDF
(4,999K)
|
|
Top |
|
|
